Búsqueda | Portal de Búsqueda de la BVS Colombia

1.

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.

DeAngelo, Daniel J; Jonas, Brian A; Liesveld, Jane L; Bixby, Dale L; Advani, Anjali S; Marlton, Paula; Magnani, John L; Thackray, Helen M; Feldman, Eric J; O'Dwyer, Michael E; Becker, Pamela S.

Blood ; 139(8): 1135-1146, 2022 02 24.

Artículo en Inglés | MEDLINE | ID: mdl-34543383

2.

Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML.

Lancet, Jeffrey E; Cortes, Jorge E; Hogge, Donna E; Tallman, Martin S; Kovacsovics, Tibor J; Damon, Lloyd E; Komrokji, Rami; Solomon, Scott R; Kolitz, Jonathan E; Cooper, Maureen; Yeager, Andrew M; Louie, Arthur C; Feldman, Eric J.

Blood ; 123(21): 3239-46, 2014 May 22.

Artículo en Inglés | MEDLINE | ID: mdl-24687088

3.

Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML.

Cortes, Jorge E; Goldberg, Stuart L; Feldman, Eric J; Rizzeri, David A; Hogge, Donna E; Larson, Melissa; Pigneux, Arnaud; Recher, Christian; Schiller, Gary; Warzocha, Krzysztof; Kantarjian, Hagop; Louie, Arthur C; Kolitz, Jonathan E.

Cancer ; 121(2): 234-42, 2015 Jan 15.

Artículo en Inglés | MEDLINE | ID: mdl-25223583

4.

Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia.

Karp, Judith E; Vener, Tatiana I; Raponi, Mitch; Ritchie, Ellen K; Smith, B Douglas; Gore, Steven D; Morris, Lawrence E; Feldman, Eric J; Greer, Jacqueline M; Malek, Sami; Carraway, Hetty E; Ironside, Valerie; Galkin, Steven; Levis, Mark J; McDevitt, Michael A; Roboz, Gail R; Gocke, Christopher D; Derecho, Carlo; Palma, John; Wang, Yixin; Kaufmann, Scott H; Wright, John J; Garret-Mayer, Elizabeth.

Blood ; 119(1): 55-63, 2012 Jan 05.

Artículo en Inglés | MEDLINE | ID: mdl-22001391

5.

Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort.

Hammami, M Bakri; Verceles, Jhannine Alyssa; Goldfinger, Mendel; Shah, Nishi; Sica, R Alejandro; Mantzaris, Ioannis; Kornblum, Noah; Konopleva, Marina; Shastri, Aditi; Shapiro, Lauren C; Feldman, Eric J; Gritsman, Kira; Verma, Amit; Cooper, Dennis L.

Transplant Cell Ther ; 30(5): 544.e1-544.e8, 2024 May.

Artículo en Inglés | MEDLINE | ID: mdl-38417677

6.

Septic shock caused by Klebsiella pneumoniae carbapenemase-producing Enterobacter gergoviae in a neutropenic patient with leukemia.

Satlin, Michael J; Jenkins, Stephen G; Chen, Liang; Helfgott, David; Feldman, Eric J; Kreiswirth, Barry N; Schuetz, Audrey N.

J Clin Microbiol ; 51(8): 2794-6, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-23761145

7.

Too much ara-C? Not enough daunorubicin?

Feldman, Eric J.

Blood ; 117(8): 2299-300, 2011 Feb 24.

Artículo en Inglés | MEDLINE | ID: mdl-21350058

8.

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML.

Scandura, Joseph M; Roboz, Gail J; Moh, Michelle; Morawa, Ewelina; Brenet, Fabienne; Bose, J Robi; Villegas, Luis; Gergis, Usama S; Mayer, Sebastian A; Ippoliti, Cindy M; Curcio, Tania J; Ritchie, Ellen K; Feldman, Eric J.

Blood ; 118(6): 1472-80, 2011 Aug 11.

Artículo en Inglés | MEDLINE | ID: mdl-21613261

9.

A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML.

Levitz, David; Saunthararajah, Yogen; Fedorov, Kateryna; Shapiro, Lauren C; Mantzaris, Ioannis; Shastri, Aditi; Kornblum, Noah; Sica, R Alejandro; Shah, Nishi; Konopleva, Marina; Gritsman, Kira; Braunschweig, Ira; Cooper, Dennis L; Pradhan, Kith; Verma, Amit; Feldman, Eric J; Goldfinger, Mendel.

Clin Cancer Res ; 29(15): 2774-2780, 2023 Aug 01.

Artículo en Inglés | MEDLINE | ID: mdl-37341641

10.

Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.

Karp, Judith E; Flatten, Karen; Feldman, Eric J; Greer, Jacqueline M; Loegering, David A; Ricklis, Rebecca M; Morris, Lawrence E; Ritchie, Ellen; Smith, B Douglas; Ironside, Valerie; Talbott, Timothy; Roboz, Gail; Le, Son B; Meng, Xue Wei; Schneider, Paula A; Dai, Nga T; Adjei, Alex A; Gore, Steven D; Levis, Mark J; Wright, John J; Garrett-Mayer, Elizabeth; Kaufmann, Scott H.

Blood ; 113(20): 4841-52, 2009 May 14.

Artículo en Inglés | MEDLINE | ID: mdl-19109557

11.

Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid Leukemia.

Li, Fu; Sutherland, May Kung; Yu, Changpu; Walter, Roland B; Westendorf, Lori; Valliere-Douglass, John; Pan, Lucy; Cronkite, Ashley; Sussman, Django; Klussman, Kerry; Ulrich, Michelle; Anderson, Martha E; Stone, Ivan J; Zeng, Weiping; Jonas, Mechthild; Lewis, Timothy S; Goswami, Maitrayee; Wang, Sa A; Senter, Peter D; Law, Che-Leung; Feldman, Eric J; Benjamin, Dennis R.

Mol Cancer Ther ; 17(2): 554-564, 2018 02.

Artículo en Inglés | MEDLINE | ID: mdl-29142066

12.

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphoma.

Roboz, Gail J; Bennett, John M; Coleman, Morton; Ritchie, Ellen K; Furman, Richard R; Rossi, Adrianna; Jhaveri, Komal; Feldman, Eric J; Leonard, John P.

Leuk Res ; 31(8): 1141-4, 2007 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-17475326

13.

PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia.

Giles, Francis J; List, Alan F; Carroll, Michael; Cortes, Jorge E; Valickas, Joyce; Chen, Bee-Lian; Masson, Eric; Jacques, Christian; Laurent, Dirk; Albitar, Maher; Feldman, Eric J; Roboz, Gail J.

Leuk Res ; 31(7): 891-7, 2007 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-17560285

14.

Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma.

Roberts, John D; Smith, Mitchell R; Feldman, Eric J; Cragg, Louise; Millenson, Michael M; Roboz, Gail J; Honeycutt, Connie; Thune, Rose; Padavic-Shaller, Kristin; Carter, W Hans; Ramakrishnan, Viswanathan; Murgo, Anthony J; Grant, Steven.

Clin Cancer Res ; 12(19): 5809-16, 2006 Oct 01.

Artículo en Inglés | MEDLINE | ID: mdl-17020988

15.

Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.

Feldman, Eric J; Brandwein, Joseph; Stone, Richard; Kalaycio, Matt; Moore, Joseph; O'Connor, Julie; Wedel, Nancy; Roboz, Gail J; Miller, Carole; Chopra, Raj; Jurcic, Joseph C; Brown, Randy; Ehmann, W Christopher; Schulman, Philip; Frankel, Stanley R; De Angelo, Daniel; Scheinberg, David.

J Clin Oncol ; 23(18): 4110-6, 2005 Jun 20.

Artículo en Inglés | MEDLINE | ID: mdl-15961759

16.

Antibody-Based Treatment of Acute Myeloid Leukemia.

Garfin, Phillip M; Feldman, Eric J.

Curr Hematol Malig Rep ; 11(6): 545-552, 2016 12.

Artículo en Inglés | MEDLINE | ID: mdl-27734262

17.

Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.

Leonard, John P; Coleman, Morton; Ketas, Jamie C; Chadburn, Amy; Furman, Richard; Schuster, Michael W; Feldman, Eric J; Ashe, Michelle; Schuster, Stephen J; Wegener, William A; Hansen, Hans J; Ziccardi, Heather; Eschenberg, Michael; Gayko, Urte; Fields, Scott Z; Cesano, Alessandra; Goldenberg, David M.

Clin Cancer Res ; 10(16): 5327-34, 2004 Aug 15.

Artículo en Inglés | MEDLINE | ID: mdl-15328168

18.

Novel Therapeutics for Therapy-Related Acute Myeloid Leukemia: 2014.

Feldman, Eric J.

Clin Lymphoma Myeloma Leuk ; 15 Suppl: S91-3, 2015 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-26297287

19.

Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome.

Roboz, Gail J; Khoury, H Jean; Jabbour, Elias; Session, Wilena; Ritchie, Ellen K; Miao, Harry; Faderl, Stefan; Zheng, Wei; Feldman, Eric J; Arellano, Martha; Morrison, J Gilmour; Ravandi, Farhad.

Leuk Lymphoma ; 56(2): 395-400, 2015 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-24794806

20.

Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase.

Giles, Francis J; Feldman, Eric J; Roboz, Gail J; Larson, Richard A; Mamus, Steven W; Cortes, Jorge E; Verstovsek, Srdan; Faderl, Stefan; Talpaz, Moshe; Beran, Miloslav; Albitar, Maher; O'Brien, Susan M; Kantarjian, Hagop M.

Leuk Res ; 27(12): 1091-6, 2003 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-12921945

Portal de Búsqueda de la BVS Colombia

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: